CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- 4 Planned sale President sold 15,000 shares at $138.16 ($2,072,400)
- 4 Other acquisition Chief Executive Officer acquired 26,840 shares (other)
- 4 Planned sale Director sold 15,000 shares at an average $147.20 ($2,208,071)
- 4 Open-market sale Director sold 202,832 shares at an average $148.34 ($30,087,339)
- 4 Planned sale Chief Legal Officer sold 5,178 shares at $148.09 ($766,785)
- 4 Planned sale Director sold 15,000 shares at an average $151.25 ($2,268,804)
- 4 Planned sale Chief Financial Officer sold 691 shares at $140.72 ($97,237)
- 4 Planned sale President sold 339 shares at $140.72 ($47,704)
- 4 Planned sale Chief Legal Officer sold 122 shares at $140.72 ($17,168)
- 4 Planned sale Director sold 20,000 shares at an average $145.08 ($2,901,585)
- 4 Planned sale Chief Financial Officer sold 183 shares at $144.50 ($26,444)
- 4 Planned sale Chief Legal Officer sold 183 shares at $144.50 ($26,444)
- 4 Planned sale President sold 341 shares at $144.50 ($49,276)
- 4 Planned sale Chief Financial Officer sold 648 shares at $162.47 ($105,283)
- 4 Planned sale Chief Legal Officer sold 1,296 shares at $162.47 ($210,566)
- 4 Planned sale Director sold 15,000 shares at an average $157.57 ($2,363,556)
- 4 Planned sale Director sold 15,000 shares at an average $127.32 ($1,909,863)
- 4 Planned sale President sold 15,000 shares at $127.49 ($1,912,350)
- 4 Planned sale President sold 255 shares at $120.96 ($30,844)
- 4 Planned sale Director sold 15,000 shares at an average $121.68 ($1,825,220)
Page 8 of 54 · 1,067 filings